Despite a cautious VC climate and ongoing geopolitical jitters, European startups are still attracting serious cash.

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. LONDON and BOSTON, June 17, 2025 /PRNewswire/ ...

Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly established ...

17.06.2025 – 13:31 Isomorphic Labs Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence London and Boston (ots/PRNewswire) ...

Publicado 17/06/2025 13:31 - Comunicado - Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence (Información remitida por la empresa firmante) ...

Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...

Isomorphic Labs is headquartered in London and has office locations in Lausanne, Switzerland and Cambridge, Massachusetts. For more information, go to and follow us on LinkedIn and X .